Vahid Eslami | Cardiology | Best Researcher Award

Assoc. Prof. Dr. Vahid Eslami | Cardiology | Best Researcher Award

Assoc. Prof. Dr. Vahid Eslami, Shahid Modarres hospital, Iran

Assoc. Prof. Dr. Vahid Eslami is a board-certified Interventional Cardiologist and Structural Heart Specialist based in Tehran, Iran. With over 14 years of experience, he specializes in high-risk coronary interventions, TAVI, CTO angioplasty, and advanced cardiac imaging (IVUS, OCT). πŸ₯ As Head of the Cardiovascular Department at Shahid Beheshti University, he leads clinical education and research, boasting 50+ peer-reviewed publications and an H-index of 11. πŸŽ“ A Fellow of the American College of Cardiology and member of ESC, EAPCI, and ISOIC, Dr. Eslami actively mentors cardiology trainees and presents at global cardiology congresses.

Publication Profile

Google Scholar

Professional Experience

Assoc. Prof. Dr. Vahid Eslami is a distinguished Interventional Cardiologist and Head of the Cardiovascular Department at Shahid Beheshti Medical University, Tehran. With over a decade of clinical and academic excellence, he has led multidisciplinary teams, performed over 500 complex coronary interventions, and implemented advanced imaging technologies like IVUS and OCT. πŸ“ˆ He has overseen impactful research, contributing to 20+ high-impact publications and international conference presentations. πŸ₯ As a medical educator, he has trained over 100 cardiology residents and fellows. πŸ§‘β€βš•οΈ A respected leader and national board member for myocardial infarction treatment, he actively shapes Iran’s cardiovascular protocols. 🌍

πŸŽ“ Education & Medical Training

Dr. Vahid Eslami completed his Doctor of Medicine (MD) at Tehran University of Medical Sciences (1999–2006), ranking 11th among 300,000 applicants in the national entrance exam. πŸ… He pursued a Cardiology Residency (2006–2010) at Shahid Beheshti University of Medical Sciences, where his thesis on QT dispersion post-primary PCI was published in a U.S. journal. πŸ«€ He then completed a Fellowship in Interventional Cardiology (2012–2014) at the same university, focusing on coronary angiography and FFR, with his research again featured in international journals. πŸ“˜ His training solidified his expertise in advanced cardiovascular care and research

πŸ… Licenses & Certifications

Dr. Vahid Eslami is a board-certified Interventional Cardiologist, accredited by the American College of Cardiology (ACC) πŸŽ“. He holds active memberships in several esteemed cardiology organizations, including the American College of Cardiology , the European Association of Percutaneous Cardiovascular Interventions (EAPCI) , and the Iranian Society of Interventional Cardiology (ISOIC) . These affiliations reflect his global engagement and adherence to the highest standards of cardiovascular care.His certifications and memberships support his ongoing contributions to research, education, and innovation in interventional cardiology.

πŸ§ πŸ”¬ Research Focus

Assoc. Prof. Dr. Vahid Eslami’s research is deeply rooted in interventional cardiology, with significant contributions to COVID-19 cardiovascular outcomes , anticoagulation therapies, and ischemic heart disease. His studies focus on complex coronary interventions, QT interval dynamics, inflammatory biomarkers, and gender differences in cardiac risk. He’s actively involved in randomized controlled trials and has examined the visual-functional mismatch in coronary diagnostics. He also explores the role of epicardial fat and cardiac imaging indices in disease progression. His multidisciplinary work bridges clinical practice and cardiovascular research, advancing protocols for acute and critical care cardiology

Publication Top Notes

  • πŸ“„ Effect of intermediate-dose vs standard-dose prophylactic anticoagulation… – πŸ“Š738 citations | πŸ“…2021

  • πŸ“„ Intermediate-dose versus standard-dose prophylactic anticoagulation in patients with COVID-19… – πŸ“Š87 citations | πŸ“…2022

  • πŸ“„ Atorvastatin versus placebo in patients with covid-19 in intensive care… – πŸ“Š76 citations | πŸ“…2022

  • πŸ“„ Evaluation of QT, QT dispersion, and T-wave peak to end time changes… – πŸ“Š61 citations | πŸ“…2013

  • πŸ“„ Association of CT-measured cardiac indices with lung involvement in COVID-19 – πŸ“Š48 citations | πŸ“…2021

  • πŸ“„ Are women more susceptible to ischemic heart disease? A literature overview – πŸ“Š36 citations | πŸ“…2021

  • πŸ“„ Epicardial adipose tissue, inflammatory biomarkers and COVID-19 – πŸ“Š31 citations | πŸ“…2021

  • πŸ“„ Extrinsic compression of left main coronary artery by the pulmonary trunk… – πŸ“Š28 citations | πŸ“…2009

  • πŸ“„ Management of STEMI during COVID-19: Iranian β€œ247” National Committee’s position paper – πŸ“Š26 citations | πŸ“…2021

  • πŸ“„ Prognostic value of inflammatory biomarkers in COVID-19 patients – πŸ“Š15 citations | πŸ“…2021

Shixun Wang | Cardiology | Best Researcher Award

Dr. Shixun Wang | Cardiology | Best Researcher Award

Professor at Weifang People’s Hospital, China

Dr. Wang Shixun πŸ‘¨β€βš•οΈ, born in October 1979, is a distinguished cardiovascular specialist at Weifang People’s Hospital. He earned his doctorate in Cardiovascular Medicine from Weifang Medical College in 2006 and has over 18 years of clinical experience. Currently serving as Deputy Director, he is applying for the position of Chief Physician πŸ‘¨β€πŸ”¬. Known for his excellence in clinical practice, he received top evaluation ratings from 2018 to 2021 🌟. Dr. Wang demonstrates strong computer and foreign language skills πŸ’»πŸ—£οΈ and is highly respected for his dedication to cardiovascular care and hospital leadership ❀️πŸ₯.

Publication Profile

Scopus

Orcid

Academic Background

Dr. Wang Shixun πŸ‘¨β€βš•οΈ graduated from Weifang Medical College in July 2006 πŸŽ“, earning his doctorate in Cardiovascular Medicine ❀️. Immediately after graduation, he began his medical career at Weifang People’s Hospital πŸ₯, demonstrating a seamless transition from academic training to clinical practice. With a strong foundation in medical education and a passion for patient care πŸ’‰, Dr. Wang quickly established himself as a dedicated healthcare professional. His long-term commitment to the same institution reflects both loyalty and deep institutional knowledge πŸ“˜, making him a valuable asset to the hospital and the broader medical community 🌟.

Professional Experience

Dr. Wang Shixun πŸ‘¨β€βš•οΈ obtained his current professional and technical qualifications in March 2017 and has since shown remarkable growth in the field of Cardiovascular Medicine ❀️. He was first appointed to his current role in September 2018 and has accumulated five years of dedicated service in this position. Dr. Wang now applies for the title of Chief Physician, reflecting his advanced clinical expertise and leadership readiness 🧠. He also serves as Deputy Director πŸ₯, balancing administrative responsibilities with medical duties. Additionally, he has demonstrated proficiency in computer applications πŸ’», enhancing his effectiveness in modern healthcare delivery.

Awards and Honors

Dr. Wang Shixun πŸ‘¨β€βš•οΈ has consistently demonstrated excellence in his medical career, earning outstanding performance evaluations for four consecutive yearsβ€”2018, 2019, 2020, and 2021 πŸ…. These “Excellent” ratings reflect his dedication, clinical skill, and strong work ethic in the field of Cardiovascular Medicine ❀️. In 2022, he continued to maintain a high standard with a “Qualified” rating βœ…. His consistent recognition by peers and superiors underscores his commitment to medical excellence and patient care πŸ™Œ. These honors highlight Dr. Wang’s growing influence and leadership within the hospital and the broader medical community πŸ₯✨.

Research Focus

Dr. Wang Shixun πŸ‘¨β€βš•οΈ is deeply engaged in the field of Cardiovascular Medicine, with a strong focus on clinical research aimed at improving patient outcomes and advancing treatment strategies for heart-related conditions β€οΈπŸ«€. His work emphasizes evidence-based practices, integrating the latest medical advancements into routine care πŸ§¬πŸ“Š. As Deputy Director at Weifang People’s Hospital πŸ₯, he actively participates in research initiatives and fosters a collaborative environment for innovation and knowledge sharing πŸ€πŸ’‘. With his solid academic foundation and practical experience, Dr. Wang continues to explore new frontiers in cardiovascular healthcare to benefit patients and the medical community πŸŒπŸ“š.

Publication Top Notes

πŸ“ A Case of Treatment With a Combination of Covered Stents and Artificial Blood Vessel for Iliac Artery Rupture During Transcatheter Aortic Valve Replacement

πŸ“… Year: 2025 | πŸ“š Journal: Clinical Case Reports

Efficacy and Safety of Different Dosing Regimens of Colchicine in Patients with Coronary Artery Disease: A Network Meta-analysis of 15 Randomized Controlled Trials

Effect of levocarnitine on TIMP-1, ICAM-1 expression of rats with coronary heart disease and its myocardial protection effect

Serum Amyloid a Promotes Visfatin Expression in Macrophages

Plumbagin mediates cardioprotection against myocardial ischemia/reperfusion injury through Nrf-2 signaling

Conclusion

Dr. Wang Shixun is a highly skilled and experienced medical professional in the field of Cardiovascular Medicine, currently serving as Deputy Director at Weifang People’s Hospital and applying for the position of Chief Physician. With a doctoral degree and nearly two decades of clinical service since 2006, he has consistently demonstrated excellence, as reflected in multiple years of outstanding evaluations. He also shows proficiency in foreign languages and computer applications. However, while his clinical credentials and leadership are commendable, there is currently limited evidence of significant research contributionsβ€”such as peer-reviewed publications, funded projects, or academic impactβ€”needed to support a strong case for a Best Researcher Award.